Federated Hermes
EDIT icon

Federated Hermes’s Editas Medicine EDIT Stock Holding History

Federated Hermes’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.84K Buy
1,150
+403
+54% +$853 ﹤0.01% 1948
2025
Q4 		$1.53K Buy
+747
New +$2.16K ﹤0.01% 1988
2023
Q4 		– Sell
-1,941
Closed -$15.1K – 2081
2023
Q3 		$15.1K Hold
1,941
– – ﹤0.01% 1786
2023
Q2 		$16K Buy
+1,941
New +$16.9K ﹤0.01% 1801
2023
Q1 		– Sell
-8,292
Closed -$73.5K – 2157
2022
Q4 		$73.5K Buy
8,292
+2,376
+40% +$26.1K ﹤0.01% 1663
2022
Q3 		$72K Buy
5,916
+229
+4% +$3.57K ﹤0.01% 1639
2022
Q2 		$67K Buy
+5,687
New +$76.2K ﹤0.01% 1651
2021
Q3 		– Sell
-232,192
Closed -$13.2M – 2246
2021
Q2 		$13.2M Sell
232,192
-408,079
-64% -$15.1M 0.02% 580
2021
Q1 		$26.9M Sell
640,271
-1,077,804
-63% -$61.4M 0.05% 421
2020
Q4 		$120M Buy
1,718,075
+11,775
+0.7% +$484K 0.25% 105
2020
Q3 		$47.9M Buy
1,706,300
+2,000
+0.1% +$65.1K 0.11% 217
2020
Q2 		$50.4M Buy
1,704,300
+267,500
+19% +$6.99M 0.12% 189
2020
Q1 		$28.5M Hold
1,436,800
– – 0.08% 261
2019
Q4 		$42.5M Hold
1,436,800
– – 0.09% 246
2019
Q3 		$32.7M Buy
1,436,800
+679,600
+90% +$16.8M 0.08% 254
2019
Q2 		$18.7M Buy
757,200
+151,700
+25% +$3.62M 0.05% 372
2019
Q1 		$14.8M Buy
605,500
+39,800
+7% +$901K 0.04% 426
2018
Q4 		$12.9M Buy
565,700
+69,800
+14% +$1.9M 0.04% 412
2018
Q3 		$15.8M Buy
495,900
+185,568
+60% +$6M 0.04% 408
2018
Q2 		$11.1M Buy
310,332
+55,232
+22% +$1.96M 0.03% 419
2018
Q1 		$8.46M Buy
255,100
+222,300
+678% +$7.92M 0.02% 478
2017
Q4 		$1.01M Buy
+32,800
New +$826K ﹤0.01% 1223

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes's EDIT Position: Q1 2026 in Review

Federated Hermes increased its Editas Medicine (EDIT) stake by 54% in Q1 2026, buying an estimated $853 and bringing the position to 1,150 shares worth $2.84K. The position accounts for ﹤0.01% of the portfolio, ranked #1948.

Federated Hermes first reported a position in EDIT in Q4 2017 and has held it in 22 quarters since. The position peaked at $120M in Q4 2020. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Federated Hermes held 1,150 shares of Editas Medicine worth $2.84K as of Q1 2026.
  • Federated Hermes bought 403 Editas Medicine shares in Q1 2026, an estimated $853.
  • Editas Medicine made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1948 holding.
  • Federated Hermes first reported a position in Editas Medicine in Q4 2017 and has held it in 22 quarters since.
  • Federated Hermes's Editas Medicine position peaked at $120M in Q4 2020.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.